About US
Contact us
-
Purdue’s hydrocodone bitartrate tablets granted priority review designationPurdue Pharma has been granted priority review designation by the US Food and Drug Administration (FDA) for its hydrocodone bitartrate extended-release tablets for treatment of chronic pain. The once2014/7/10
-
AstraZeneca’s Forxiga receives positive advice from Scottish Medicines ConsortiumAstraZeneca announced that the Scottish Medicines Consortium (SMC) has issued positive advice for use of its Forxiga, a selective and reversible inhibitor of sodium-glucose co-transporter-2, as part o2014/7/10
-
Roche receives Japanese approval for lung cancer therapyThe Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Roche's alectinib for treatment of people living with non-small cell lung cancer (NSCLC) that is anaplastic lymphoma kinase fusi2014/7/9
-
CHMP recommends Teva’s pregnancy prevention drugThe European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending the marketing authorisation of Teva Pharmaceutical's Seasonique f2014/7/9
-
GSK and Theravance announce Japanese approval for Anoro ElliptaGlaxoSmithKline (GSK) and Theravance have obtained approval from the Japanese Ministry of Health, Labour and Welfare for Anoro Ellipta to treat chronic obstructive pulmonary disease (COPD). The Japan2014/7/8
-
Forest Laboratories completes acquisition of Furiex PharmaceuticalsActavis subsidiary Forest Laboratories has completed the acquisition of Furiex Pharmaceuticals, a US-based drug development collaboration company. Forest Laboratories has acquired Furiex in an all-ca2014/7/8
-
GSK and Genmab receive European approval for ArzerraGlaxoSmithKline (GSK) and Genmab have received European Commission marketing authorisation for Arzerra as first-line treatment for chronic lymphocytic leukaemia in combination with chlorambucil or ben2014/7/7
-
FDA grants priority review designation for Boehringer’s idiopathic pulmonary fibrosis therapyThe US Food and Drug Administration (FDA) has accepted the filing of Boehringer Ingelheim Pharmaceuticals' new drug application for its nintedanib and has granted priority review designation for treat2014/7/7
-
Genentech to acquire Seragon PharmaceuticalsRoche Group member Genentech has entered into a definitive agreement to acquire the US-based biotechnology company Seragon Pharmaceuticals. Under the tagreement, Seragon Pharmaceuticals will receive2014/7/4
-
Argentina approves Genzyme’s Lemtrada for multiple sclerosisSanofi subsidiary Genzyme has received approval from the Argentina's National Administration of Drugs, Food and Medical Technology (ANMAT) for its Lemtrada (alemtuzumab) for treatment of multiple scle2014/7/4